Kaposi's sarcoma presenting as generalized lymphedema.
Identifieur interne : 005603 ( PubMed/Curation ); précédent : 005602; suivant : 005604Kaposi's sarcoma presenting as generalized lymphedema.
Auteurs : E. Frans [Belgique] ; D. Blockmans ; W. Peetermans ; D. Knockaert ; H. BobbaersSource :
- Acta clinica Belgica [ 1784-3286 ] ; 1994.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anticorps anti-VIH (isolement et purification), Humains, Interféron de type I (usage thérapeutique), Lymphoedème (étiologie), Mâle, Protéines recombinantes, Sarcome de Kaposi (), Sarcome de Kaposi (traitement médicamenteux), Séropositivité VIH (), Séropositivité VIH (diagnostic), Technique de Western, Test ELISA.
- MESH :
- diagnostic : Séropositivité VIH.
- isolement et purification : Anticorps anti-VIH.
- traitement médicamenteux : Sarcome de Kaposi.
- usage thérapeutique : Interféron de type I.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Humains, Mâle, Protéines recombinantes, Sarcome de Kaposi, Séropositivité VIH, Technique de Western, Test ELISA.
English descriptors
- KwdEn :
- Blotting, Western, Enzyme-Linked Immunosorbent Assay, HIV Antibodies (isolation & purification), HIV Seropositivity (complications), HIV Seropositivity (diagnosis), Humans, Interferon Type I (therapeutic use), Lymphedema (etiology), Male, Middle Aged, Recombinant Proteins, Sarcoma, Kaposi (complications), Sarcoma, Kaposi (drug therapy).
- MESH :
- chemical , isolation & purification : HIV Antibodies.
- complications : HIV Seropositivity, Sarcoma, Kaposi.
- diagnosis : HIV Seropositivity.
- drug therapy : Sarcoma, Kaposi.
- etiology : Lymphedema.
- chemical , therapeutic use : Interferon Type I.
- Blotting, Western, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Recombinant Proteins.
Abstract
We present a HIV-1 seropositive patient with generalized lymphedema, due to a rare lymphangiomatous variant of Kaposi's sarcoma, successfully treated with interferon-alpha. The clinical presentation and treatment possibilities of Kaposi's sarcoma are reviewed.
PubMed: 8191811
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005603
Links to Exploration step
pubmed:8191811Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Kaposi's sarcoma presenting as generalized lymphedema.</title><author><name sortKey="Frans, E" sort="Frans, E" uniqKey="Frans E" first="E" last="Frans">E. Frans</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven</wicri:regionArea></affiliation></author><author><name sortKey="Blockmans, D" sort="Blockmans, D" uniqKey="Blockmans D" first="D" last="Blockmans">D. Blockmans</name></author><author><name sortKey="Peetermans, W" sort="Peetermans, W" uniqKey="Peetermans W" first="W" last="Peetermans">W. Peetermans</name></author><author><name sortKey="Knockaert, D" sort="Knockaert, D" uniqKey="Knockaert D" first="D" last="Knockaert">D. Knockaert</name></author><author><name sortKey="Bobbaers, H" sort="Bobbaers, H" uniqKey="Bobbaers H" first="H" last="Bobbaers">H. Bobbaers</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1994">1994</date><idno type="RBID">pubmed:8191811</idno><idno type="pmid">8191811</idno><idno type="wicri:Area/PubMed/Corpus">005603</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005603</idno><idno type="wicri:Area/PubMed/Curation">005603</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005603</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Kaposi's sarcoma presenting as generalized lymphedema.</title><author><name sortKey="Frans, E" sort="Frans, E" uniqKey="Frans E" first="E" last="Frans">E. Frans</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven</wicri:regionArea></affiliation></author><author><name sortKey="Blockmans, D" sort="Blockmans, D" uniqKey="Blockmans D" first="D" last="Blockmans">D. Blockmans</name></author><author><name sortKey="Peetermans, W" sort="Peetermans, W" uniqKey="Peetermans W" first="W" last="Peetermans">W. Peetermans</name></author><author><name sortKey="Knockaert, D" sort="Knockaert, D" uniqKey="Knockaert D" first="D" last="Knockaert">D. Knockaert</name></author><author><name sortKey="Bobbaers, H" sort="Bobbaers, H" uniqKey="Bobbaers H" first="H" last="Bobbaers">H. Bobbaers</name></author></analytic><series><title level="j">Acta clinica Belgica</title><idno type="ISSN">1784-3286</idno><imprint><date when="1994" type="published">1994</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blotting, Western</term><term>Enzyme-Linked Immunosorbent Assay</term><term>HIV Antibodies (isolation & purification)</term><term>HIV Seropositivity (complications)</term><term>HIV Seropositivity (diagnosis)</term><term>Humans</term><term>Interferon Type I (therapeutic use)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Middle Aged</term><term>Recombinant Proteins</term><term>Sarcoma, Kaposi (complications)</term><term>Sarcoma, Kaposi (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anticorps anti-VIH (isolement et purification)</term><term>Humains</term><term>Interféron de type I (usage thérapeutique)</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Protéines recombinantes</term><term>Sarcome de Kaposi ()</term><term>Sarcome de Kaposi (traitement médicamenteux)</term><term>Séropositivité VIH ()</term><term>Séropositivité VIH (diagnostic)</term><term>Technique de Western</term><term>Test ELISA</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>HIV Antibodies</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Seropositivity</term><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Séropositivité VIH</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Sarcoma, Kaposi</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Anticorps anti-VIH</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Interferon Type I</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Sarcome de Kaposi</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Interféron de type I</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blotting, Western</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Recombinant Proteins</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Mâle</term><term>Protéines recombinantes</term><term>Sarcome de Kaposi</term><term>Séropositivité VIH</term><term>Technique de Western</term><term>Test ELISA</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We present a HIV-1 seropositive patient with generalized lymphedema, due to a rare lymphangiomatous variant of Kaposi's sarcoma, successfully treated with interferon-alpha. The clinical presentation and treatment possibilities of Kaposi's sarcoma are reviewed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8191811</PMID><DateCreated><Year>1994</Year><Month>06</Month><Day>23</Day></DateCreated><DateCompleted><Year>1994</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1784-3286</ISSN><JournalIssue CitedMedium="Print"><Volume>49</Volume><Issue>1</Issue><PubDate><Year>1994</Year></PubDate></JournalIssue><Title>Acta clinica Belgica</Title><ISOAbbreviation>Acta Clin Belg</ISOAbbreviation></Journal><ArticleTitle>Kaposi's sarcoma presenting as generalized lymphedema.</ArticleTitle><Pagination><MedlinePgn>19-22</MedlinePgn></Pagination><Abstract><AbstractText>We present a HIV-1 seropositive patient with generalized lymphedema, due to a rare lymphangiomatous variant of Kaposi's sarcoma, successfully treated with interferon-alpha. The clinical presentation and treatment possibilities of Kaposi's sarcoma are reviewed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frans</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Universitaire Ziekenhuizen, K.U. Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blockmans</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Peetermans</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Knockaert</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Bobbaers</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Clin Belg</MedlineTA><NlmUniqueID>0370306</NlmUniqueID><ISSNLinking>1784-3286</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006679" MajorTopicYN="N">HIV Seropositivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8191811</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005603 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005603 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:8191811
|texte= Kaposi's sarcoma presenting as generalized lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:8191811" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |